Publications
Scientific Journal Articles
2022
Hulshof, E. C., Deenen, M. J., Nijenhuis, M., Soree, B., de Boer-Veger, N. J., Buunk, A.-M., Houwink E. J. F., Risselada, A., Rongen, G. A. P. J. M., van Schaik, R. H. N., Touw, D. J., van der Weide, J., van Westrhenen, R., Deneer, V. H. M., Guchelaar, H.-J., and Swen J. J. Dutch pharmacogenetics working group (DPWG) guideline for the gene–drug interaction between UGT1A1 and irinotecan. European Journal of Human Genetics. https://doi.org/10.1038/s41431-022-01243-2
2021
Brouwer, J. M. J. L., Nijenhuis, M., Soree, Bianca; Guchelaar, H.-J, Swen, J. J., van Schaik, R. H. N., van der Weide, J., Rongen, G. A. P. J. M., Buunk, A.-M., de Boer-Veger, N. J., Houwink, E. J. F., van Westrhenen, R., Wilffert, B., Deneer, V. H. M., and Mulder, H. (2021). Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2C19 and CYP2D6 and SSRIs. European Journal of Human Genetics. https://doi.org/10.1038/s41431-021-01004-7
van Westrhenen, R., van Schaik, R. H. N., van Gelder, T., Birkenhager, T. K., Bakker, P. R., Houwink, E. J. F., Bet, P. M., Hoogendijk, W. J. G., and van Weelden-Hulshof, M. J. M. (2021). Policy and Practice Review: A First Guideline on the Use of Pharmacogenetics in Clinical Psychiatric Practice. Frontiers in Pharmacology, 12, 640032. https://doi.org/10.3389/fphar.2021.640032
van Westrhenen, R., and Ingelman-Sundberg, M. (2021). Editorial: From Trial and Error to Individualised Pharmacogenomics-Based Pharmacotherapy in Psychiatry. Frontiers in Pharmacology, 12, 725565. https://doi.org/10.3389/fphar.2021.725565
Conference Contributions
Oral
2022
van Westrhenen, R. (2022) Pharmacogenetics in Psychiatry: Current Status Quo. International Society for Affective Disorders.
Goes, F. and van Westrhenen, R. (2022). Pre-Congress Course: The State of the Art of Psychiatric Genetics & Pharmacogenetics. 22nd World Congress of Psychiatry.
van Westrhenen, R. (2022) Phenotype vs Genotype. 11th Biennial Conference on Signal Detection and Signal Management in Pharmacovigilance. Drug Safety Research Unit.
2021
van Westrhenen, R. (2021) PRESIDENTIAL FORUM - Genetics & Psychiatry: Expectations & achievements. 21st WPA World Congress of Psychiatry Virtual Congress.
van Westrhenen, R. (2021) Pharmacogenomics in Psychiatry – The Global Perspective: A Town Hall Meeting (Discussant). WCPG 2021: Virtual World Congress of Psychiatric Genetics.
Poster
2021
Heilbronner, U., Young, A. H., Juruena, M., Vieta, E., Jimenez, E., Kas, M. J., Jukic, M., Nöthen, M., Philipsen, A., Kilarski, L., Kaprio, J., Ingelman-Sundberg, M., Rossner, M., Wichert, S., Moldovan, R., Rutten, B., Guloksuz, S., Schruers, K., Shomron, N., Schulze, T. G., Ng, R. M. K., Olisa, N., Van der Eycken, E., Budde, M., van Hell, E., and van Westrhenen, R. (2021) PSY-PGx – A New Intervention for Implementation of Pharmacogenetics in Psychiatry. WCPG 2021: Virtual World Congress of Psychiatric Genetics.
Other
2022
Kane, E. (2022) Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2C19 and CYP2D6 and SSRIs, Brouwer et al. Journal Club - The Maudsley Training Programme, King's College London.
van Westrhenen, R. (2022) Pharmacogenetics in Psychiatry. Journal Club - The Maudsley Training Programme, King's College London.
2021
van Westrhenen, R. (2021) Implementation of Pharmacogenetics in Psychiatry. UMC Utrecht Clinical Trial Center webinar: latest developments in psychosis research.